SE7511408L - Forfarnde for framstellning av karbamid- eller tiokarbamidderivat - Google Patents

Forfarnde for framstellning av karbamid- eller tiokarbamidderivat

Info

Publication number
SE7511408L
SE7511408L SE7511408A SE7511408A SE7511408L SE 7511408 L SE7511408 L SE 7511408L SE 7511408 A SE7511408 A SE 7511408A SE 7511408 A SE7511408 A SE 7511408A SE 7511408 L SE7511408 L SE 7511408L
Authority
SE
Sweden
Prior art keywords
thiokarbamide
urban
derivatives
procedure
preparation
Prior art date
Application number
SE7511408A
Other languages
English (en)
Inventor
K Arumura
M Konishi
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of SE7511408L publication Critical patent/SE7511408L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7511408A 1974-10-12 1975-10-10 Forfarnde for framstellning av karbamid- eller tiokarbamidderivat SE7511408L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49117503A JPS5152176A (sv) 1974-10-12 1974-10-12

Publications (1)

Publication Number Publication Date
SE7511408L true SE7511408L (sv) 1976-04-13

Family

ID=14713345

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7511408A SE7511408L (sv) 1974-10-12 1975-10-10 Forfarnde for framstellning av karbamid- eller tiokarbamidderivat

Country Status (7)

Country Link
JP (1) JPS5152176A (sv)
AU (1) AU8564375A (sv)
BE (1) BE834247A (sv)
DE (1) DE2545501A1 (sv)
FR (1) FR2287228A1 (sv)
NL (1) NL7511857A (sv)
SE (1) SE7511408L (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
GB1561023A (en) * 1977-04-22 1980-02-13 Beecham Group Ltd 2-methoxy - 5 - chloro aniline derivatives
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
PL128510B1 (en) * 1980-03-01 1984-02-29 Wyeth John & Brother Ltd Method of obtaining new piperidine derivatives
US4722930A (en) * 1980-03-01 1988-02-02 John Wyeth And Brother Limited 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and derivatives
FI95572C (sv) * 1987-06-22 1996-02-26 Eisai Co Ltd Förfarande för framställning av ett som läkemedel användbart piperidinderivat eller dess farmaceutiska salt
AUPP818099A0 (en) 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
SI1587789T1 (sl) 2003-01-16 2009-02-28 Acadia Pharm Inc Selektivni inverzni agonisti serotoninskega 2A/2Creceptorja kot terapevtiki za nevrodegenerativne bolezni
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
EP2134330B1 (en) 2007-03-19 2013-05-08 Acadia Pharmaceuticals Inc. Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
HUE055763T2 (hu) 2015-07-20 2021-12-28 Acadia Pharm Inc Eljárás N-(4-fluorbenzil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metil-propil-oxi)fenil-metil)karbamid vagy ennek tartarát-sója és C polimorf formája elõállítására
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
EP3558311A1 (en) 2016-12-20 2019-10-30 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
EP3615028A1 (en) 2017-04-28 2020-03-04 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
EP3675827A1 (en) 2017-08-30 2020-07-08 Acadia Pharmaceuticals Inc. Formulations of pimavanserin
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Also Published As

Publication number Publication date
DE2545501A1 (de) 1976-04-22
JPS5152176A (sv) 1976-05-08
AU8564375A (en) 1977-04-21
FR2287228A1 (fr) 1976-05-07
NL7511857A (nl) 1976-04-14
BE834247A (fr) 1976-02-02

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7511408L (sv) Forfarnde for framstellning av karbamid- eller tiokarbamidderivat
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE7900773L (sv) Nytt forfarande for framstellning av foreningen amoxycillin
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE431547B (sv) Forfarande for framstellning av 3-metylencefamsulfoxider
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7505751L (sv) Forfarande for framstellning av cefalosporiner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE420097B (sv) Forfarande for framstellning av hydroxialkylxantiner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
SE7513759L (sv) Forfarande for framstellning av oxoalkylmonolkylxantiner
SE7505066L (sv) Forfarande for framstellning av cefalsporinderivat.
NO142814C (no) Fremgangsmaate for fremstilling av dibenzofuran